Over the last two decades, the healthcare sector has proven to be one of the most reliable wealth creators. Unlike trend-driven industries, healthcare thrives on essentials—insurance, life-saving drugs, medical devices, and surgical innovation. That combination has delivered steady growth, resilient margins, and strong cash flows for both companies and their shareholders. To get a deeper look at the numbers behind this story, watch the video embedded below.
Take UnitedHealth Group, for instance. With over 150 million people under its care and a business that blends insurance, healthcare delivery, and digital tools, it continues to post double-digit earnings growth. On the pharmaceutical side, Eli Lilly’s breakthrough diabetes and obesity drugs are expected to generate tens of billions in annual revenue, while Merck’s Keytruda has reshaped cancer treatment and become one of the highest-grossing drugs worldwide. Both have consistently turned this growth into shareholder value through dividends and buybacks.
Then there’s Johnson & Johnson and Intuitive Surgical, leaders in medical devices and surgical robotics. J&J brings decades of stability with a AAA credit rating and six decades of dividend increases, while Intuitive Surgical is expanding robotic-assisted procedures with a recurring revenue model that investors love. Together, these companies show why healthcare isn’t just essential to everyday life—it’s also one of the most dependable long-term investment opportunities.
Disclaimer: Investments in securities markets are subject to market risks. Read all the related documents carefully before investing.
